A framework for selecting innovation funding mechanism depending on whether a policymaker can articulate the problem, specify the solution, or identify a team to contract with, from Clancy, Esche, Haria, McMahon, Snyder, and Watney www.nber.org/papers/w35549
We’ve thought a lot about matching the right problem with the right innovation funding mechanism at @uchi-msa.bsky.social and @ifp.bsky.social. All of it captured in this paper: www.nber.org/papers/w35549
Selecting Innovation Funding Mechanisms: A Framework for Policymakers
Founded in 1920, the NBER is a private, non-profit, non-partisan organization dedicated to conducting economic research and to disseminating research findings among academics, public policy makers, an...
nber.org
The AI boom could unlock $37B–$100B in new annual philanthropy. @charlesjkenny.bsky.social argues a maximum vaccination strategy, developing and rolling out vaccines for diseases affecting the world's poorest people, could be one of the most effective investments. https://go.cgdev.org/4yN1su5
Use New Philanthropy for a Maximum Vaccination Strategy
Nan Ransohoff suggests AI-related wealth may add $37 to $100 billion per year in philanthropic spending in the near future. This blog suggest that support for a maximum vaccination strategy focused on...
go.cgdev.org
Can $50 billion a year in new philanthropy be spent well? We think so! @rglenner.bsky.social and I suggest institutions that could move money at that scale toward cost-effective programs.
The AI boom could generate $37B–$100B in annual philanthropy. How can it be spent effectively? In the first blog of a new CGD series, @rglenner.bsky.social and @leahrosenzweig.bsky.social examine large-scale implementers, intermediaries, and quick wins. www.cgdev.org/blog/we-can-...
The World Bank's proposed Day Zero Financing Framework could help countries access vaccines faster during the next pandemic. @rglenner.bsky.social, @siddhharia.bsky.social, and Sebastian Quaade outline practical steps to get the framework across the finish line. go.cgdev.org/3Sz5HZT
The World Bank Has Invested $3 Billion in Drinking Water. We Don’t Know if the Water Has Lead. www.cgdev.org/blog/world-b...
The World Bank Has Invested $3 Billion in Drinking Water. We Don’t Know if the Water Has Lead.
The World Bank lending portfolio currently includes over $3 billion for 81 active water supply projects across low- and middle-income countries. Not one project includes lead testing in drinking…
cgdev.org
Meanwhile, @hannahkeenan.bsky.social looks back at joining the civil service as part of the 'Brexit cohort'. www.instituteforgovernment.org.uk/comment/brex...
The Atlas of Innovation, developed by @uchi-msa.bsky.social and @ifp.bsky.social, helps policymakers and philanthropists identify which funding approaches best suit different innovation challenges. 🧭 Sarrin Chethik, @siddhharia.bsky.social, and Christopher Snyder explain 👉 go.cgdev.org/3QxaBG1
The Atlas of Innovation: A New Tool for Navigating the Innovation Funding Landscape
The United States government spends close to $200 billion annually on research and development. Every dollar counts, as innovation is crucial to solving pressing social problems and the ultimate driver of economic growth.
go.cgdev.org
Last week, MSA launched the Atlas of Innovation with @ifp.bsky.social. The Atlas helps policymakers, philanthropists, and development banks choose HOW to fund innovation. Today’s blog post describes why we made the Atlas and how it works: www.marketshapingaccelerator.org/research/the...
The Atlas of Innovation: A New Tool for Navigating the Innovation Funding Landscape - Market Shaping Accelerator
By Sarrin Chethik, Siddhartha Haria, and Christopher Snyder The United States government spends close to $200 billion annually on research and development. Every dollar counts, as innovation is crucia...
marketshapingaccelerator.org
Check out our new Atlas of Innovation at atlasofinnovation.org - economic insights and beautiful web design!
Choosing how to fund innovation can be just as important as choosing what to fund. The Atlas of Innovation helps policymakers and philanthropies navigate the tradeoffs between 13 funding approaches—from grants to prizes to advance market commitments. 🧭 Explore the tool: atlasofinnovation.org/
@uchi-msa.bsky.social and @ifp.bsky.social have been thinking hard about how to fund innovation. The Atlas of Innovation helps policymakers match innovation problems to the right funding tool.
Choosing how to fund innovation can be just as important as choosing what to fund. The Atlas of Innovation helps policymakers and philanthropies navigate the tradeoffs between 13 funding approaches—from grants to prizes to advance market commitments. 🧭 Explore the tool: atlasofinnovation.org/
Choosing how to fund innovation can be just as important as choosing what to fund. The Atlas of Innovation helps policymakers and philanthropies navigate the tradeoffs between 13 funding approaches—from grants to prizes to advance market commitments. 🧭 Explore the tool: atlasofinnovation.org/
My @uchi-msa.bsky.social colleagues Sarrin Chethik and Christopher Snyder in the Wall Street Journal making the case for pull incentives for generic drug repurposing. Pull incentives would motivate firms to find new uses for off-patent drugs saving lives and money. www.wsj.com/opinion/you-...
Opinion | You Can Teach an Old Drug New Tricks
Aspirin prevents heart attacks, and good policy could give other generic drugs a second life.
wsj.com
As the UK cuts aid, how can it make the most of a smaller budget? @rglenner.bsky.social and @siddhharia.bsky.social make the case for “radical simplification.” That means focusing where impact is greatest—innovation, evidence-based programs, and the poorest countries. https://go.cgdev.org/4m7fZuL
Radical Simplification: What Are the Implications for UK Aid?
The Foreign Secretary recently set out how the UK plans to cut aid to 0.23 percent of GNI (this figure excludes domestic refugee costs). Last year, we called for the radical simplification of aid as a...
cgdev.org
The G20 High Level Independent Panel also recommends that MDBs enable at-risk financing for advance purchases of medical countermeasures during pandemics. nam.edu/pandemic-fin...
Pandemic Financing
The G20 High Level Independent Panel sets minimum annual benchmarks for pandemic financing and urges governments to take action by or before the September
nam.edu
The World Bank board is discussing at-risk financing this week. Are MDBs ready to help countries borrow for vaccines and therapeutics before regulatory approval during the next pandemic? @rglenner.bsky.social and Masyita Crystallin argue they must. www.project-syndicate.org/commentary/m...
Ensuring Pandemic Financing for Middle-Income Countries
Masyita Crystallin & Rachel Glennerster call on multilateral development banks to commit now to providing at-risk funding for bets on vaccines.
project-syndicate.org
Listen to my colleagues Sarrin Chethik and Chris Snyder on the freakonomics podcast. They’ve been thinking hard about designing incentives for finding new uses for off-patent drugs.
Novel treatments could come from old drugs💊 if we create incentives to test them for new diseases. The latest @freakonomics.bsky.social featured our work on generic drug repurposing. Super proud of this team: Chris Snyder + Sarrin Chethik @uchi-msa.bsky.social! 🎧 freakonomics.com/podcast/are-...
Novel treatments could come from old drugs💊 if we create incentives to test them for new diseases. The latest @freakonomics.bsky.social featured our work on generic drug repurposing. Super proud of this team: Chris Snyder + Sarrin Chethik @uchi-msa.bsky.social! 🎧 freakonomics.com/podcast/are-...
freakonomics.com
Looking forward to speaking on this panel next week - so much shifting so quickly at the foreign office at the moment and there's a big and (I think) v interesting convo in there about how we scrutinise aid spend.
The future of the @icai_uk — the UK’s independent watchdog for foreign aid — is uncertain. @sarahchampionmp.bsky.social and @hannahkeenan.bsky.social discuss how aid should be scrutinised in this @cgdev.org discussion. 📅 24 Feb 2026 Register: buff.ly/Bm4ISqE
My co-author Leah R. Rosenzweig wrote a blog post about a social media experiment we ran on vaccine hesitancy in Kenya and Nigeria www.cgdev.org/blog/us-just...
The US Just Changed Vaccine Guidance. Can AI Help Families Decide?
Vaccines are among the most impactful global health innovations. They drive major declines in child mortality and prevent an estimated 3.5 to 5 million deaths every year. The golden age of vaccine dev...
cgdev.org
Pull mechanisms like advance market commitments and prizes can drive innovation—but how large should the incentive be? A new Pull Incentive Sizing Tool from the Market Shaping Accelerator offers a practical way to translate uncertainty: https://go.cgdev.org/4bjRl6L
How Big Should a Pull Incentive Be? A New Pull Incentive Sizing Tool to Foster Innovation
Pull mechanisms, like advance market commitments (AMCs) and prizes, that pay for results are having a moment. After the landmark pneumococcal AMC helped accelerate access to lifesaving vaccines, the m...
go.cgdev.org
Big new blogpost! My guide to data visualization, which includes a very long table of contents, tons of charts, and more. --> Why data visualization matters and how to make charts more effective, clear, transparent, and sometimes, beautiful. www.scientificdiscovery.dev/p/salonis-gu...
Newly-approved vaccines are safe & effective, but are they reaching as many people, saving as many lives, & stretching budgets as far as possible? 💉 Witold Więcek & @jmadankeller.bsky.social argue that optimizing vaccine doses is a high-impact opportunity ⬇️ https://go.cgdev.org/3WZwCgt
Smarter Vaccine Doses: A High-Impact Fix for Global Immunization
Hundreds of millions of dollars are typically spent developing a new vaccine. You would assume that by the time the vaccine receives approval, we would know precisely the right dosing regimen: how muc...
go.cgdev.org
Importantly, making unfair dismissal a "Day One" right would likely have been counterproductive for workers. It would induce firms not to "take a chance" on candidates who seem risky or have unusual profiles. ...
The Government is right to keep but reduce ‘qualifying periods’ for unfair dismissal protection. Making unfair dismissal a ‘day one’ right would have taken the UK from one internation extreme to another.
*external validity voice* actually it could just be that nairobi is fucking awesome
There are those in the development sector that try to romanticize rural life, but most people really are happier living around lots of other people voxdev.org/topic/migrat...
The World Bank plans to “operationally align” its research arm. But the changes could undermine its ability to deliver rigorous, independent analysis free from client or internal pressure. More from @charlesjkenny.bsky.social and @eeshani.bsky.social ⬇️ https://go.cgdev.org/43vNSgK
The World Bank Group Reorganization: A Retreat from Research Quality?
A recent PowerPoint presentation presents the outline for the institutional structure of “The WBG Knowledge Bank.” But a knowledge bank owes it to its stakeholders impartial and transparent considerat...
go.cgdev.org
New G20 High Level Independent Panel on pandemic preparedness out. Recommendation 3: Enabling at-risk financing for low and middle income countries is crucial to ensuring low and middle income countries get the vaccines and therapeutics they need during the next outbreak
MSA is hiring: centerforglobaldevelopment.applytojob.com/apply/oYXbeB... @uchi-msa.bsky.social @cgdev.org
Research Assistant, Market Shaping Accelerator - Center for Global Development - Career Page
Apply to Research Assistant, Market Shaping Accelerator at Center for Global Development in Washington, DC.
centerforglobaldevelopment.applytojob.com
"The Big Returns to Early Investments in Foundational Literacy and Numeracy" Join us in DC (or online) Oct 17 2025 to discuss the latest evidence with Jishnu Das, Jo Bourne, Jennifer Swift-Morgan, @daveevansphd.bsky.social www.cgdev.org/event/big-re...